摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-2,4-dichloro-6-(2-(pyridin-2-yl)vinyl)pyrimidine

中文名称
——
中文别名
——
英文名称
trans-2,4-dichloro-6-(2-(pyridin-2-yl)vinyl)pyrimidine
英文别名
2,4-dichloro-6-[(E)-2-pyridin-2-ylethenyl]pyrimidine
trans-2,4-dichloro-6-(2-(pyridin-2-yl)vinyl)pyrimidine化学式
CAS
——
化学式
C11H7Cl2N3
mdl
——
分子量
252.103
InChiKey
ZZDVOKFQZFVNEE-SNAWJCMRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    38.7
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    吡啶-2-甲醛2,4-二氯-6-甲基嘧啶 在 sodium hydride 、 三乙胺 作用下, 以 四氢呋喃 、 mineral oil 为溶剂, 反应 0.67h, 以30%的产率得到trans-2,4-dichloro-6-(2-(pyridin-2-yl)vinyl)pyrimidine
    参考文献:
    名称:
    TETRA-ARYL CYCLOBUTANE INHIBITORS OF ANDROGEN RECEPTOR ACTION FOR THE TREATMENT OF HORMONE REFRACTORY CANCER
    摘要:
    本公开提供了四取代环丁烷抑制剂的雄激素受体作用,并使用这些抑制剂的方法,用于治疗激素难治性癌症。
    公开号:
    US20160229811A1
点击查看最新优质反应信息

文献信息

  • TETRA-ARYL CYCLOBUTANE INHIBITORS OF ANDROGEN RECEPTOR ACTION FOR THE TREATMENT OF HORMONE REFRACTORY CANCER
    申请人:THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    公开号:US20160229811A1
    公开(公告)日:2016-08-11
    The present disclosure provides tetra-substituted cyclobutane inhibitors of Androgen Receptor Action, and methods of using such inhibitors, for the treatment of hormone-refractory cancers.
    本公开提供了四取代环丁烷抑制剂的雄激素受体作用,并使用这些抑制剂的方法,用于治疗激素难治性癌症。
  • [EN] TETRA-ARYL CYCLOBUTANE INHIBITORS OF ANDROGEN RECEPTOR ACTION FOR THE TREATMENT OF HORMONE REFRACTORY CANCER<br/>[FR] INHIBITEURS TÉTRA-ARYLE-CYCLOBUTANE DE L'ACTION DU RÉCEPTEUR DES ANDROGÈNES POUR LE TRAITEMENT D'UN CANCER RÉFRACTAIRE AUX HORMONES
    申请人:UNIV ILLINOIS
    公开号:WO2015048246A1
    公开(公告)日:2015-04-02
    The present disclosure provides tetra-substituted cyclobutane inhibitors of Androgen Receptor Action, and methods of using such inhibitors, for the treatment of hormone-refractory cancers.
    本公开提供了四取代环丁烷抑制剂,用于雄激素受体作用的抑制剂,并提供了使用这些抑制剂治疗激素难治性癌症的方法。
  • US9868705B2
    申请人:——
    公开号:US9868705B2
    公开(公告)日:2018-01-16
  • π–π Interaction Energies as Determinants of the Photodimerization of Mono-, Di-, and Triazastilbenes
    作者:Alexander A. Parent、Daniel H. Ess、John A. Katzenellenbogen
    DOI:10.1021/jo500457n
    日期:2014.6.20
    We describe the quantitative [2 + 2] photo-cycloaddition of crystalline trans-2,4-dichloro-6-styrylpyrimidine to produce the corresponding htt r-ctt cyclobutane dimer, and we present H-1 NMR analysis of the photolysis of this and six other mono-, di-, and triazastilbenes in solid and solution states. Density functional (M06-2X) and correlated ab initio (MP2) calculations were used to obtain interaction energies I between two monomers of each azastilbene. These energies mirror the relative polarization of the stilbene moieties and can be quantitatively correlated with the rate of reaction and selective formation of the htt r-ctt dimers. In the solid state, poor correlation is observed between interaction energy and reactivity/selectivity. This lack of correlation is explained through X-ray analysis of the azastilbene monomers and is shown to be in accordance with the principles of Schmidt's topochemical postulate. Conversely, in solution there is a strong positive correlation (R-2 = 0.96) between interaction energies and formation of the htt rat dimer. These results are the first to show this correlation and to demonstrate the utility of calculated interaction energies as a tool for the prediction of stereo- and regioselectivity in solution-state stilbene-type photocycloadditions.
查看更多